Summary of Original Version
Amend KRS 304-17A.148 to cap the cost-sharing requirements for prescription insulin at $30 per 30 day supply; amend KRS 18A.225 to require the Kentucky Employee Health Plan to comply; EFFECTIVE January 1, 2022.
Summary of Amendment: House Committee Substitute 1
Summary
Retain original provisions; delete provision prohibiting an insurer with a cost-sharing requirment of less than $30 for a 30 day supply of prescription inuslin on the effective date of this Act from increasing that cost-sharing requirement; define "cost sharing."
Summary of Amendment: Senate Committee Substitute 1
Summary
Retain original provisions; increase cap on cost-sharing requirements for prescription insulin to $35 for a 30 day supply; EFFECTIVE January 1, 2022.
Summary of Amendment: Senate Floor Amendment 1 -- J. Carpenter
Summary
Delete delayed effective date and replace with emergency clause. EMERGENCY.
Summary of Amendment: Senate Floor Amendment 2 -- J. Carpenter
Summary
Make title amendment.
Summary of Amendment: Senate Floor Amendment 3 -- J. Carpenter
Summary
Provide that section on diabetes coverage is subject to federal law and regulations; delete delayed effective date and replace with emergency clause. EMERGENCY.